BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8593465)

  • 1. Augmentation of tumor immunity by 6-mercaptopurine (6-MP) and its analogs in the double grafted tumor system in mice.
    Kashida T; Narasaki N; Sakai A; Tsujihara K; Tsuzurahara K; Takeyama S
    Biol Pharm Bull; 1995 Nov; 18(11):1492-7. PubMed ID: 8593465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the mechanism of immunopotentiating antitumor effect of 6-MPG, a water-soluble derivative of 6-mercaptopurine.
    Kashida T; Narasaki N; Sakai A; Tsujihara K; Tsuzurahara K; Naito K; Takeyama S
    Immunopharmacology; 1997 Aug; 37(1):95-104. PubMed ID: 9285248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of tumor immunity by 6-MPG, a water-soluble derivative of 6-mercaptopurine, in mice.
    Kashida T; Narasaki N; Tsujihara K; Naito K; Takeyama S
    Int J Immunopharmacol; 1996 May; 18(5):311-9. PubMed ID: 8933210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of tumor immunity in mice by intralesional injection of vitamin A.
    Kashida T; Narasaki N; Yano T; Tsuzurahara K; Takeyama S
    Biol Pharm Bull; 1998 Apr; 21(4):339-45. PubMed ID: 9586569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Augmentation of sinecomitant immunity in mice by gamma-(9H-purine-6-yl)thiomethyl L-glutamate (6-MPG), a water-soluble derivative of 6-mercaptopurine.
    Kashida T; Narasaki N; Tsujihara K; Naito K; Takeyama S
    Biol Pharm Bull; 1998 Jan; 21(1):16-21. PubMed ID: 9477163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effect of PSK: role of regional lymph nodes and enhancement of concomitant and sinecomitant immunity in the mouse.
    Ebina T; Kohya H; Ishikawa K
    Jpn J Cancer Res; 1989 Feb; 80(2):158-66. PubMed ID: 2498250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of T-cell-mediated immunity against MethA fibrosarcoma by intratumoral injections of a bacillus Calmette-Guérin nucleic acid fraction.
    Kuramoto E; Yano O; Shimada S
    Cancer Immunol Immunother; 1992; 34(5):283-8. PubMed ID: 1371719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor activity of astaxanthin and its mode of action.
    Jyonouchi H; Sun S; Iijima K; Gross MD
    Nutr Cancer; 2000; 36(1):59-65. PubMed ID: 10798217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant activity of the cell wall of Bifidobacterium infantis for in vivo immune responses in mice.
    Sekine K; Watanabe-Sekine E; Toida T; Kasashima T; Kataoka T; Hashimoto Y
    Immunopharmacol Immunotoxicol; 1994 Nov; 16(4):589-609. PubMed ID: 7876463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antitumor effect of PSK at a distant site: tumor-specific immunity and combination with other chemotherapeutic agents.
    Ebina T; Murata K
    Jpn J Cancer Res; 1992 Jul; 83(7):775-82. PubMed ID: 1517151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "double grafted tumor system", proposed to find effector cells in the analyses of antitumor effect of BRMs.
    Kohya H; Ebina T; Yamaguchi T; Ishida N
    Biotherapy; 1989; 1(3):139-51. PubMed ID: 2534966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose cyclophosphamide inhibition of transplantable fibrosarcoma growth by augmentation of the host immune response.
    Ray PK; Raychaudhuri S
    J Natl Cancer Inst; 1981 Dec; 67(6):1341-5. PubMed ID: 6947115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CCI52 sensitizes tumors to 6-mercaptopurine and inhibits MYCN-amplified tumor growth.
    Huynh T; Murray J; Flemming CL; Kamili A; Hofmann U; Cheung L; Roundhill EA; Yu DMT; Webber HT; Schwab M; Henderson MJ; Haber M; Norris MD; Fletcher JI
    Biochem Pharmacol; 2020 Feb; 172():113770. PubMed ID: 31862449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiated immune responses after administration of aclacinomycin.
    Orbach-Arbouys S; Andrade-Mena CE; Berardet M; Mathe G
    Int Arch Allergy Appl Immunol; 1982; 68(2):117-21. PubMed ID: 7042586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor and immunomodulatory properties of artemether and its ability to reduce CD4+ CD25+ FoxP3+ T reg cells in vivo.
    Farsam V; Hassan ZM; Zavaran-Hosseini A; Noori S; Mahdavi M; Ranjbar M
    Int Immunopharmacol; 2011 Nov; 11(11):1802-8. PubMed ID: 21824530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of radiation on tumor-specific delayed-type hypersensitivity (DTH) response in mice].
    Kawahara S; Hashimoto T; Hachisu R
    Nihon Igaku Hoshasen Gakkai Zasshi; 1989 May; 49(5):675-80. PubMed ID: 2798059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 6-mercaptopurine promotes energetic failure in proliferating T cells.
    Fernández-Ramos AA; Marchetti-Laurent C; Poindessous V; Antonio S; Laurent-Puig P; Bortoli S; Loriot MA; Pallet N
    Oncotarget; 2017 Jun; 8(26):43048-43060. PubMed ID: 28574837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Water-soluble antitumor agents. I. Synthesis and biological activity of 6-S-aminoacyloxymethyl mercaptopurine derivatives.
    Harada N; Hongu M; Tanaka T; Kashida T; Narasaki N; Ohohashi M; Oda K; Hashiyama T; Tsujihara K
    Chem Pharm Bull (Tokyo); 1995 Oct; 43(10):1793-6. PubMed ID: 8536352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antitumor effect of PSK (2): effector mechanism of the antimetastatic effect in the "double grafted tumor system"].
    Ebina T; Kohya H
    Gan To Kagaku Ryoho; 1987 Jun; 14(6 Pt 1):1847-53. PubMed ID: 3592718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Depression of protective mechanisms against ectromelia virus infection in tumor-bearing mice and its prevention by PSK].
    Taniguchi M; Tsuru S; Kitani H; Zinnaka Y; Nomoto K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2760-5. PubMed ID: 6095765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.